Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The human microbiota is an aggregate of microorganisms residing in the human body, mostly in the gastrointestinal tract. Human microbiome modulators are described as modulators that have the potential to modulate the microbiome to render beneficial effect on the human body.
The global human microbiome modulator market has maintained a stable annual growth rate of approximately 6.0% from 2015 to 2017. The market is expected to grow at a compound annual growth rate of 11.6% from 2018 to 2026.
Some government agencies around the world are already reorganizing their regulatory policies and regulations to expand access to advanced and cost-effective medical technologies to reduce economic, social and clinical burdens. Therefore, it is believed that the emergence of precision medical methods is expected to promote a paradigm shift in the healthcare industry. Human microbiome modulators are described as modulators that have the potential to modulate the microbiome to produce beneficial effects on the human body. With the advent of this field, precision care has been significantly enhanced to actually provide beneficial therapeutic effects.
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Human Microbiome Modulators market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Human Microbiome Modulators market. Detailed analysis of key players, along with key growth strategies adopted by Human Microbiome Modulators industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Sanofi
Hansen Holding A / S
Koninklijke DSM NV
Bayer AG
Procter and Gamble Company
Probi AB
EI du Pont de Nemours
Yakult Honsha Co，Ltd
BioGaia AB
By Type:
Probiotics and Creams
Prebiotics and Dietary Supplements
Drugs
By End-User:
Digestive Health
Immune Health
Oral Health
Others
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Human Microbiome Modulators Market
-
1.3 Market Segment by Type
-
1.3.1 USA Human Microbiome Modulators Market Size and Growth Rate of Probiotics and Creams from 2016 to 2027
-
1.3.2 USA Human Microbiome Modulators Market Size and Growth Rate of Prebiotics and Dietary Supplements from 2016 to 2027
-
1.3.3 USA Human Microbiome Modulators Market Size and Growth Rate of Drugs from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Human Microbiome Modulators Market Size and Growth Rate of Digestive Health from 2016 to 2027
-
1.4.2 USA Human Microbiome Modulators Market Size and Growth Rate of Immune Health from 2016 to 2027
-
1.4.3 USA Human Microbiome Modulators Market Size and Growth Rate of Oral Health from 2016 to 2027
-
1.4.4 USA Human Microbiome Modulators Market Size and Growth Rate of Others from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Human Microbiome Modulators Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Human Microbiome Modulators Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Human Microbiome Modulators Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Human Microbiome Modulators Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Human Microbiome Modulators Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Human Microbiome Modulators by Major Types
-
3.4.1 Market Size and Growth Rate of Probiotics and Creams
-
3.4.2 Market Size and Growth Rate of Prebiotics and Dietary Supplements
-
3.4.3 Market Size and Growth Rate of Drugs
4 Segmentation of Human Microbiome Modulators Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Human Microbiome Modulators by Major End-Users
-
4.4.1 Market Size and Growth Rate of Human Microbiome Modulators in Digestive Health
-
4.4.2 Market Size and Growth Rate of Human Microbiome Modulators in Immune Health
-
4.4.3 Market Size and Growth Rate of Human Microbiome Modulators in Oral Health
-
4.4.4 Market Size and Growth Rate of Human Microbiome Modulators in Others
5 Market Analysis by Regions
-
5.1 USA Human Microbiome Modulators Production Analysis by Regions
-
5.2 USA Human Microbiome Modulators Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Human Microbiome Modulators Landscape Analysis
-
6.1 West USA Human Microbiome Modulators Landscape Analysis by Major Types
-
6.2 West USA Human Microbiome Modulators Landscape Analysis by Major End-Users
7 South USA Human Microbiome Modulators Landscape Analysis
-
7.1 South USA Human Microbiome Modulators Landscape Analysis by Major Types
-
7.2 South USA Human Microbiome Modulators Landscape Analysis by Major End-Users
8 Middle West USA Human Microbiome Modulators Landscape Analysis
-
8.1 Middle West USA Human Microbiome Modulators Landscape Analysis by Major Types
-
8.2 Middle West USA Human Microbiome Modulators Landscape Analysis by Major End-Users
9 Northeast USA Human Microbiome Modulators Landscape Analysis
-
9.1 Northeast USA Human Microbiome Modulators Landscape Analysis by Major Types
-
9.2 Northeast USA Human Microbiome Modulators Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 Sanofi
-
10.1.1 Sanofi Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 Hansen Holding A / S
-
10.2.1 Hansen Holding A / S Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 Koninklijke DSM NV
-
10.3.1 Koninklijke DSM NV Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 Bayer AG
-
10.4.1 Bayer AG Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 Procter and Gamble Company
-
10.5.1 Procter and Gamble Company Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 Probi AB
-
10.6.1 Probi AB Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
-
10.7 EI du Pont de Nemours
-
10.7.1 EI du Pont de Nemours Company Profile and Recent Development
-
10.7.2 Market Performance
-
10.7.3 Product and Service Introduction
-
10.8 Yakult Honsha Co，Ltd
-
10.8.1 Yakult Honsha Co，Ltd Company Profile and Recent Development
-
10.8.2 Market Performance
-
10.8.3 Product and Service Introduction
-
10.9 BioGaia AB
-
10.9.1 BioGaia AB Company Profile and Recent Development
-
10.9.2 Market Performance
-
10.9.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Human Microbiome Modulators Market Size and Growth Rate of Probiotics and Creams from 2016 to 2027
-
Figure USA Human Microbiome Modulators Market Size and Growth Rate of Prebiotics and Dietary Supplements from 2016 to 2027
-
Figure USA Human Microbiome Modulators Market Size and Growth Rate of Drugs from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Human Microbiome Modulators Market Size and Growth Rate of Digestive Health from 2016 to 2027
-
Figure USA Human Microbiome Modulators Market Size and Growth Rate of Immune Health from 2016 to 2027
-
Figure USA Human Microbiome Modulators Market Size and Growth Rate of Oral Health from 2016 to 2027
-
Figure USA Human Microbiome Modulators Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Human Microbiome Modulators Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Human Microbiome Modulators Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Human Microbiome Modulators Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Human Microbiome Modulators Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Human Microbiome Modulators Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Human Microbiome Modulators
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Human Microbiome Modulators by Different Types from 2016 to 2027
-
Table Consumption Share of Human Microbiome Modulators by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Probiotics and Creams
-
Figure Market Size and Growth Rate of Prebiotics and Dietary Supplements
-
Figure Market Size and Growth Rate of Drugs
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Human Microbiome Modulators by Different End-Users from 2016 to 2027
-
Table Consumption Share of Human Microbiome Modulators by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Digestive Health
-
Figure Market Size and Growth Rate of Immune Health
-
Figure Market Size and Growth Rate of Oral Health
-
Figure Market Size and Growth Rate of Others
-
Table USA Human Microbiome Modulators Production by Regions
-
Table USA Human Microbiome Modulators Production Share by Regions
-
Figure USA Human Microbiome Modulators Production Share by Regions in 2016
-
Figure USA Human Microbiome Modulators Production Share by Regions in 2021
-
Figure USA Human Microbiome Modulators Production Share by Regions in 2027
-
Table USA Human Microbiome Modulators Consumption by Regions
-
Table USA Human Microbiome Modulators Consumption Share by Regions
-
Figure USA Human Microbiome Modulators Consumption Share by Regions in 2016
-
Figure USA Human Microbiome Modulators Consumption Share by Regions in 2021
-
Figure USA Human Microbiome Modulators Consumption Share by Regions in 2027
-
Table West USA Human Microbiome Modulators Consumption by Types from 2016 to 2027
-
Table West USA Human Microbiome Modulators Consumption Share by Types from 2016 to 2027
-
Figure West USA Human Microbiome Modulators Consumption Share by Types in 2016
-
Figure West USA Human Microbiome Modulators Consumption Share by Types in 2021
-
Figure West USA Human Microbiome Modulators Consumption Share by Types in 2027
-
Table West USA Human Microbiome Modulators Consumption by End-Users from 2016 to 2027
-
Table West USA Human Microbiome Modulators Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Human Microbiome Modulators Consumption Share by End-Users in 2016
-
Figure West USA Human Microbiome Modulators Consumption Share by End-Users in 2021
-
Figure West USA Human Microbiome Modulators Consumption Share by End-Users in 2027
-
Table South USA Human Microbiome Modulators Consumption by Types from 2016 to 2027
-
Table South USA Human Microbiome Modulators Consumption Share by Types from 2016 to 2027
-
Figure South USA Human Microbiome Modulators Consumption Share by Types in 2016
-
Figure South USA Human Microbiome Modulators Consumption Share by Types in 2021
-
Figure South USA Human Microbiome Modulators Consumption Share by Types in 2027
-
Table South USA Human Microbiome Modulators Consumption by End-Users from 2016 to 2027
-
Table South USA Human Microbiome Modulators Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Human Microbiome Modulators Consumption Share by End-Users in 2016
-
Figure South USA Human Microbiome Modulators Consumption Share by End-Users in 2021
-
Figure South USA Human Microbiome Modulators Consumption Share by End-Users in 2027
-
Table Middle West USA Human Microbiome Modulators Consumption by Types from 2016 to 2027
-
Table Middle West USA Human Microbiome Modulators Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Human Microbiome Modulators Consumption Share by Types in 2016
-
Figure Middle West USA Human Microbiome Modulators Consumption Share by Types in 2021
-
Figure Middle West USA Human Microbiome Modulators Consumption Share by Types in 2027
-
Table Middle West USA Human Microbiome Modulators Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Human Microbiome Modulators Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Human Microbiome Modulators Consumption Share by End-Users in 2016
-
Figure Middle West USA Human Microbiome Modulators Consumption Share by End-Users in 2021
-
Figure Middle West USA Human Microbiome Modulators Consumption Share by End-Users in 2027
-
Table Northeast USA Human Microbiome Modulators Consumption by Types from 2016 to 2027
-
Table Northeast USA Human Microbiome Modulators Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Human Microbiome Modulators Consumption Share by Types in 2016
-
Figure Northeast USA Human Microbiome Modulators Consumption Share by Types in 2021
-
Figure Northeast USA Human Microbiome Modulators Consumption Share by Types in 2027
-
Table Northeast USA Human Microbiome Modulators Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Human Microbiome Modulators Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Human Microbiome Modulators Consumption Share by End-Users in 2016
-
Figure Northeast USA Human Microbiome Modulators Consumption Share by End-Users in 2021
-
Figure Northeast USA Human Microbiome Modulators Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Sanofi
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi
-
Figure Sales and Growth Rate Analysis of Sanofi
-
Figure Revenue and Market Share Analysis of Sanofi
-
Table Product and Service Introduction of Sanofi
-
Table Company Profile and Development Status of Hansen Holding A / S
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hansen Holding A / S
-
Figure Sales and Growth Rate Analysis of Hansen Holding A / S
-
Figure Revenue and Market Share Analysis of Hansen Holding A / S
-
Table Product and Service Introduction of Hansen Holding A / S
-
Table Company Profile and Development Status of Koninklijke DSM NV
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Koninklijke DSM NV
-
Figure Sales and Growth Rate Analysis of Koninklijke DSM NV
-
Figure Revenue and Market Share Analysis of Koninklijke DSM NV
-
Table Product and Service Introduction of Koninklijke DSM NV
-
Table Company Profile and Development Status of Bayer AG
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer AG
-
Figure Sales and Growth Rate Analysis of Bayer AG
-
Figure Revenue and Market Share Analysis of Bayer AG
-
Table Product and Service Introduction of Bayer AG
-
Table Company Profile and Development Status of Procter and Gamble Company
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Procter and Gamble Company
-
Figure Sales and Growth Rate Analysis of Procter and Gamble Company
-
Figure Revenue and Market Share Analysis of Procter and Gamble Company
-
Table Product and Service Introduction of Procter and Gamble Company
-
Table Company Profile and Development Status of Probi AB
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Probi AB
-
Figure Sales and Growth Rate Analysis of Probi AB
-
Figure Revenue and Market Share Analysis of Probi AB
-
Table Product and Service Introduction of Probi AB
-
Table Company Profile and Development Status of EI du Pont de Nemours
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of EI du Pont de Nemours
-
Figure Sales and Growth Rate Analysis of EI du Pont de Nemours
-
Figure Revenue and Market Share Analysis of EI du Pont de Nemours
-
Table Product and Service Introduction of EI du Pont de Nemours
-
Table Company Profile and Development Status of Yakult Honsha Co，Ltd
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Yakult Honsha Co，Ltd
-
Figure Sales and Growth Rate Analysis of Yakult Honsha Co，Ltd
-
Figure Revenue and Market Share Analysis of Yakult Honsha Co，Ltd
-
Table Product and Service Introduction of Yakult Honsha Co，Ltd
-
Table Company Profile and Development Status of BioGaia AB
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of BioGaia AB
-
Figure Sales and Growth Rate Analysis of BioGaia AB
-
Figure Revenue and Market Share Analysis of BioGaia AB
-
Table Product and Service Introduction of BioGaia AB
-
